|
Avita Medical ، Inc. (Rcel) DCF تقييم
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
AVITA Medical, Inc. (RCEL) Bundle
تُمكّنك حاسبة DCF (RCL) التي تم تصميمها من أجل الدقة ، من تقييم تقييم Avita Medical ، Inc. باستخدام البيانات المالية في العالم الحقيقي ، مما يوفر مرونة كاملة لتعديل جميع المعلمات الأساسية للتوقعات المحسنة.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2016 |
AY2 2017 |
AY3 2019 |
AY4 2020 |
AY5 2022 |
FY1 2023 |
FY2 2024 |
FY3 2025 |
FY4 2026 |
FY5 2027 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.2 | 1.3 | 20.7 | 14.3 | 50.6 | 47.4 | 44.5 | 41.8 | 39.2 | 36.8 |
| Revenue Growth, % | 0 | 6.31 | 0 | -30.99 | 0 | -6.17 | -6.17 | -6.17 | -6.17 | -6.17 |
| EBITDA | -12.5 | -18.6 | -61.2 | -41.5 | -39.6 | -45.4 | -42.6 | -40.0 | -37.5 | -35.2 |
| EBITDA, % | -1061.34 | -1478.04 | -295.97 | -291.16 | -78.26 | -95.65 | -95.65 | -95.65 | -95.65 | -95.65 |
| Depreciation | .1 | .1 | .0 | .5 | 1.5 | 2.5 | 2.3 | 2.2 | 2.1 | 1.9 |
| Depreciation, % | 11.83 | 8.4 | -0.00000000000485 | 3.26 | 2.89 | 5.28 | 5.28 | 5.28 | 5.28 | 5.28 |
| EBIT | -12.7 | -18.7 | -61.2 | -42.0 | -41.0 | -45.7 | -42.8 | -40.2 | -37.7 | -35.4 |
| EBIT, % | -1073.17 | -1486.44 | -295.97 | -294.42 | -81.15 | -96.23 | -96.23 | -96.23 | -96.23 | -96.23 |
| Total Cash | 3.8 | 14.8 | 106.7 | 73.6 | 116.5 | 47.4 | 44.5 | 41.8 | 39.2 | 36.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .2 | .2 | 3.5 | 2.4 | 5.2 | 7.4 | 6.9 | 6.5 | 6.1 | 5.7 |
| Account Receivables, % | 14.41 | 19.11 | 17.05 | 17.05 | 10.26 | 15.58 | 15.58 | 15.58 | 15.58 | 15.58 |
| Inventories | 1.0 | 1.2 | 1.6 | 1.1 | 3.1 | 19.2 | 18.0 | 16.9 | 15.8 | 14.8 |
| Inventories, % | 87.88 | 92.02 | 7.89 | 7.89 | 6.17 | 40.37 | 40.37 | 40.37 | 40.37 | 40.37 |
| Accounts Payable | 1.0 | .3 | 6.3 | 4.3 | 4.4 | 16.6 | 15.6 | 14.6 | 13.7 | 12.9 |
| Accounts Payable, % | 83.86 | 21.65 | 30.38 | 30.38 | 8.72 | 35 | 35 | 35 | 35 | 35 |
| Capital Expenditure | -.4 | -.5 | -.9 | -.8 | -.7 | -8.3 | -7.8 | -7.3 | -6.8 | -6.4 |
| Capital Expenditure, % | -36.64 | -39.29 | -4.14 | -5.94 | -1.31 | -17.46 | -17.46 | -17.46 | -17.46 | -17.46 |
| Tax Rate, % | -0.13519 | -0.13519 | -0.13519 | -0.13519 | -0.13519 | -0.13519 | -0.13519 | -0.13519 | -0.13519 | -0.13519 |
| EBITAT | -11.6 | -17.2 | -61.2 | -42.0 | -41.1 | -44.2 | -41.5 | -38.9 | -36.5 | -34.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -12.1 | -18.5 | -59.8 | -42.7 | -45.0 | -56.0 | -46.3 | -43.4 | -40.7 | -38.2 |
| WACC, % | 11.32 | 11.32 | 11.32 | 11.32 | 11.32 | 11.32 | 11.32 | 11.32 | 11.32 | 11.32 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -168.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -39 | |||||||||
| Terminal Value | -418 | |||||||||
| Present Terminal Value | -245 | |||||||||
| Enterprise Value | -413 | |||||||||
| Net Debt | -26 | |||||||||
| Equity Value | -386 | |||||||||
| Diluted Shares Outstanding, MM | 25 | |||||||||
| Equity Value Per Share | -15.46 |
What You Will Get
- Real RCEL Financial Data: Pre-filled with AVITA Medical, Inc.'s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See AVITA Medical, Inc.'s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Financial Inputs: Adjust essential metrics such as revenue projections, operating margins, and research expenditures.
- Instant DCF Valuation: Automatically computes intrinsic value, net present value (NPV), and other key financial metrics.
- High-Precision Accuracy: Leverages AVITA Medical’s real-world financial data for credible valuation results.
- Seamless Scenario Analysis: Easily evaluate various assumptions and assess their impact on outcomes.
- Efficiency Booster: Streamline the valuation process by avoiding the construction of intricate financial models from the ground up.
How It Works
- 1. Open the Template: Download and open the Excel file containing AVITA Medical, Inc.'s (RCEL) preloaded data.
- 2. Edit Assumptions: Modify key inputs such as growth rates, WACC, and capital expenditures.
- 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
- 4. Test Scenarios: Evaluate various forecasts to explore different valuation outcomes.
- 5. Use with Confidence: Present professional valuation insights to enhance your decision-making.
Why Choose This Calculator for AVITA Medical, Inc. (RCEL)?
- User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
- Customizable Inputs: Easily adjust parameters to suit your specific analysis needs.
- Real-Time Feedback: Observe immediate updates to AVITA Medical’s valuation as you modify inputs.
- Pre-Loaded Data: Comes with AVITA Medical’s actual financials for swift evaluations.
- Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling AVITA Medical, Inc. (RCEL) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for AVITA Medical, Inc. (RCEL).
- Consultants: Deliver professional valuation insights on AVITA Medical, Inc. (RCEL) to clients quickly and accurately.
- Business Owners: Understand how companies like AVITA Medical, Inc. (RCEL) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to AVITA Medical, Inc. (RCEL).
What the Template Contains
- Pre-Filled Data: Includes AVITA Medical's historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze AVITA Medical's profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.